• 文献检索
  • 文档翻译
  • 深度研究
  • 学术资讯
  • Suppr Zotero 插件Zotero 插件
  • 邀请有礼
  • 套餐&价格
  • 历史记录
应用&插件
Suppr Zotero 插件Zotero 插件浏览器插件Mac 客户端Windows 客户端微信小程序
定价
高级版会员购买积分包购买API积分包
服务
文献检索文档翻译深度研究API 文档MCP 服务
关于我们
关于 Suppr公司介绍联系我们用户协议隐私条款
关注我们

Suppr 超能文献

核心技术专利:CN118964589B侵权必究
粤ICP备2023148730 号-1Suppr @ 2026

文献检索

告别复杂PubMed语法,用中文像聊天一样搜索,搜遍4000万医学文献。AI智能推荐,让科研检索更轻松。

立即免费搜索

文件翻译

保留排版,准确专业,支持PDF/Word/PPT等文件格式,支持 12+语言互译。

免费翻译文档

深度研究

AI帮你快速写综述,25分钟生成高质量综述,智能提取关键信息,辅助科研写作。

立即免费体验

单纯B型主动脉夹层胸主动脉腔内修复术后的再次干预

Reintervention after Thoracic Endovascular Aortic Repair of Uncomplicated Type B Aortic Dissection.

作者信息

Cheng Li, Xiang Dongqiao, Zhang Shan, Zheng Chuansheng, Wu Xiaoyan

机构信息

Department of Pediatrics, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

Department of Radiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China.

出版信息

J Clin Med. 2023 Feb 10;12(4):1418. doi: 10.3390/jcm12041418.

DOI:10.3390/jcm12041418
PMID:36835969
原文链接:https://pmc.ncbi.nlm.nih.gov/articles/PMC9964661/
Abstract

BACKGROUND

Data are scarce regarding the incidence, reasons, potential risk factors, and long-term outcomes of reintervention after thoracic endovascular aortic repair (TEVAR) in patients with uncomplicated type B aortic dissection (TBAD).

METHODS

Between January 2010 and December 2020, 238 patients with uncomplicated TBAD who received TEVAR were analyzed retrospectively. The clinical baseline data, aorta anatomy, dissection characteristics, and details of the TEVAR procedure were evaluated and compared. A competing-risk regression model was used to estimate the cumulative incidences of reintervention. The multivariate Cox model was used to identify the independent risk factors.

RESULTS

The mean follow-up time was 68.6 months. A total of 27 (11.3%) cases of reintervention were observed. The competing-risk analyses showed that the 1-, 3-, and 5-year cumulative incidences of reintervention were 5.07%, 7.08%, and 14.0%, respectively. Reasons for reintervention included endoleak (25.9%), aneurysmal dilation (22.2%), retrograde type A aortic dissection (18.5%), distal stent-graft-induced new entry and false lumen expansion (18.5%), and dissection progression and/or malperfusion (14.8%). Multivariable Cox analysis demonstrated that a larger initial maximal aortic diameter (Hazard ratio [HR], 1.75; 95% Confidence interval [CI], 1.13-2.69, = 0.011) and increased proximal landing zone oversizing (HR, 1.07; 95% CI, 1.01-1.47, = 0.033) were the significant risk factors for reintervention. Long-term survival rates were comparable between patients with or without reintervention ( = 0.915).

CONCLUSIONS

Reintervention after TEVAR in patients with uncomplicated TBAD is not uncommon. A larger initial maximal aortic diameter and excessive proximal landing zone oversizing are associated with the second intervention. Reintervention does not significantly affect long-term survival.

摘要

背景

关于单纯B型主动脉夹层(TBAD)患者接受胸主动脉腔内修复术(TEVAR)后再次干预的发生率、原因、潜在风险因素和长期结局的数据较少。

方法

回顾性分析2010年1月至2020年12月期间238例接受TEVAR的单纯TBAD患者。评估并比较临床基线数据、主动脉解剖结构、夹层特征和TEVAR手术细节。采用竞争风险回归模型估计再次干预的累积发生率。采用多变量Cox模型确定独立风险因素。

结果

平均随访时间为68.6个月。共观察到27例(11.3%)再次干预病例。竞争风险分析显示,再次干预的1年、3年和5年累积发生率分别为5.07%、7.08%和14.0%。再次干预的原因包括内漏(25.9%)、动脉瘤样扩张(22.2%)、逆行性A型主动脉夹层(18.5%)、远端覆膜支架引起的新破口和假腔扩大(18.5%)以及夹层进展和/或灌注不良(14.8%)。多变量Cox分析表明,初始最大主动脉直径较大(风险比[HR],1.75;95%置信区间[CI],1.13 - 2.69,P = 0.011)和近端锚定区过大(HR,1.07;95%CI,1.01 - 1.47,P = 0.033)是再次干预的显著风险因素。有或无再次干预患者的长期生存率相当(P = 0.915)。

结论

单纯TBAD患者TEVAR术后再次干预并不少见。初始最大主动脉直径较大和近端锚定区过大与二次干预相关。再次干预对长期生存无显著影响。

https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/f4c0d1f13a8a/jcm-12-01418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/c44a6e4aeed1/jcm-12-01418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/7670e85f67e5/jcm-12-01418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/f4c0d1f13a8a/jcm-12-01418-g003.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/c44a6e4aeed1/jcm-12-01418-g001.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/7670e85f67e5/jcm-12-01418-g002.jpg
https://cdn.ncbi.nlm.nih.gov/pmc/blobs/704a/9964661/f4c0d1f13a8a/jcm-12-01418-g003.jpg

相似文献

1
Reintervention after Thoracic Endovascular Aortic Repair of Uncomplicated Type B Aortic Dissection.单纯B型主动脉夹层胸主动脉腔内修复术后的再次干预
J Clin Med. 2023 Feb 10;12(4):1418. doi: 10.3390/jcm12041418.
2
Risk factors for distal stent graft-induced new entry after endovascular repair in uncomplicated type B aortic dissection.单纯B型主动脉夹层腔内修复术后远端支架移植物导致新破口的危险因素
J Vasc Surg. 2023 Jan;77(1):37-45.e1. doi: 10.1016/j.jvs.2022.08.032. Epub 2022 Sep 1.
3
Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection.胸主动脉腔内修复术后治疗急性和慢性 B 型夹层的二次主动脉干预的意义。
J Vasc Surg. 2019 May;69(5):1367-1378. doi: 10.1016/j.jvs.2018.07.080. Epub 2018 Dec 13.
4
Incidence, Predictors, and Implications of Secondary Aortic Intervention Following Thoracic Endovascular Aortic Repair for Type B Dissection.B型夹层胸主动脉腔内修复术后二次主动脉干预的发生率、预测因素及影响
J Endovasc Ther. 2024 May 28:15266028241255549. doi: 10.1177/15266028241255549.
5
Unique characteristics of the type B aortic dissection patients with malperfusion in the Vascular Quality Initiative.血管质量倡议中存在灌注不良的 B 型主动脉夹层患者的独特特征。
J Vasc Surg. 2021 Jul;74(1):53-62. doi: 10.1016/j.jvs.2020.11.047. Epub 2021 Apr 21.
6
Reintervention after thoracic endovascular aortic repair of complicated aortic dissection.胸主动脉腔内修复术治疗复杂主动脉夹层的再次干预。
J Vasc Surg. 2014 Feb;59(2):327-33. doi: 10.1016/j.jvs.2013.08.089. Epub 2013 Oct 15.
7
Effectiveness of Proximal Landing Zone 1 and 2 Thoracic Endovascular Aortic Repair for Type B Aortic Dissection by Comparing Outcomes With Thoracic Arch Aneurysm.通过比较胸主动脉瘤的治疗结果,评估近端着陆区1和2的胸主动脉腔内修复术治疗B型主动脉夹层的有效性。
J Endovasc Ther. 2025 Feb;32(1):170-184. doi: 10.1177/15266028231174407. Epub 2023 May 24.
8
Efficacy of thoracic endovascular stent repair for chronic type B aortic dissection with aneurysmal degeneration.胸主动脉腔内支架修复术治疗伴动脉瘤样变的慢性 B 型主动脉夹层的疗效。
J Vasc Surg. 2013 Jul;58(1):10-7.e1. doi: 10.1016/j.jvs.2012.12.071. Epub 2013 Apr 3.
9
Beta-blocker use after thoracic endovascular aortic repair in patients with type B aortic dissection is associated with improved early aortic remodeling.胸主动脉腔内修复术后β受体阻滞剂在 B 型主动脉夹层患者中的应用与早期主动脉重塑改善相关。
J Vasc Surg. 2022 Dec;76(6):1477-1485.e2. doi: 10.1016/j.jvs.2022.06.100. Epub 2022 Jul 20.
10
Long-term results of total endovascular repair of arch-involving aortic pathologies using parallel grafts for supra-aortic debranching.使用平行移植物进行主动脉弓去分支术治疗累及主动脉弓的主动脉病变的全腔内修复的长期结果。
J Vasc Surg. 2022 Mar;75(3):813-823.e1. doi: 10.1016/j.jvs.2021.09.020. Epub 2021 Oct 2.

引用本文的文献

1
Midterm outcomes of thoracic endovascular aortic repair versus optimal medical therapy for uncomplicated acute type B dissection.胸主动脉腔内修复术与最佳药物治疗对单纯急性B型主动脉夹层的中期疗效比较
JTCVS Open. 2025 Jan 19;24:67-76. doi: 10.1016/j.xjon.2024.12.013. eCollection 2025 Apr.
2
Unpredictable Aortic Behavior in Identifying Risk Factors for Reintervention: A Prospective Cohort Study.识别再次干预风险因素中不可预测的主动脉行为:一项前瞻性队列研究。
Thorac Cardiovasc Surg. 2025 Sep;73(6):456-467. doi: 10.1055/s-0044-1791947. Epub 2024 Nov 18.
3
The safety and prognostic evaluation of subsequent aortic surgery after thoracic endovascular aortic repair: a retrospective cohort study.

本文引用的文献

1
Initial Thoracic Endovascular Aortic Repair vs Medical Therapy for Acute Uncomplicated Type B Aortic Dissection.急性非复杂性 B 型主动脉夹层的初始胸主动脉腔内修复术与药物治疗的比较。
JAMA Cardiol. 2023 Jan 1;8(1):44-53. doi: 10.1001/jamacardio.2022.4187.
2
The Society of Thoracic Surgeons/American Association for Thoracic Surgery Clinical Practice Guidelines on the Management of Type B Aortic Dissection.胸外科医师学会/美国胸外科协会关于B型主动脉夹层治疗的临床实践指南
Ann Thorac Surg. 2022 Apr;113(4):1073-1092. doi: 10.1016/j.athoracsur.2021.11.002. Epub 2022 Jan 25.
3
Permissive Hypertension and Selective Cerebrospinal Fluid Drainage for Extended TEVAR for Acute Type B Dissection: Reply.
胸主动脉腔内修复术后后续主动脉手术的安全性和预后评估:一项回顾性队列研究。
J Thorac Dis. 2024 Jun 30;16(6):3732-3739. doi: 10.21037/jtd-24-71. Epub 2024 Jun 18.
4
Diabetes and aortic dissection: unraveling the role of 3-hydroxybutyrate through mendelian randomization.糖尿病与主动脉夹层:通过孟德尔随机化研究 3-羟基丁酸的作用。
Cardiovasc Diabetol. 2024 May 7;23(1):159. doi: 10.1186/s12933-024-02266-3.
对于急性B型夹层的扩展胸主动脉腔内修复术,采用允许性高血压和选择性脑脊液引流:回复
Ann Thorac Surg. 2020 Oct;110(4):1435-1436. doi: 10.1016/j.athoracsur.2020.05.032. Epub 2020 Jun 25.
4
The Safety and Efficacy of Extended TEVAR in Acute Type B Aortic Dissection.急性 B 型主动脉夹层腔内修复术的安全性和疗效。
Ann Thorac Surg. 2020 Sep;110(3):799-806. doi: 10.1016/j.athoracsur.2019.12.036. Epub 2020 Mar 5.
5
Comparison of mid-term outcomes of endovascular repair and medical management in patients with acute uncomplicated type B aortic dissection.比较急性非复杂性 B 型主动脉夹层患者血管内修复与药物治疗的中期结果。
J Thorac Cardiovasc Surg. 2021 Jul;162(1):26-36.e1. doi: 10.1016/j.jtcvs.2019.11.127. Epub 2019 Dec 24.
6
Impact of Secondary Aortic Interventions After Thoracic Endovascular Aortic Repair on Long-Term Survival.胸主动脉腔内修复术后二次主动脉干预对长期生存的影响。
Ann Thorac Surg. 2020 Jul;110(1):27-38. doi: 10.1016/j.athoracsur.2019.10.015. Epub 2019 Nov 27.
7
Implications of secondary aortic intervention after thoracic endovascular aortic repair for acute and chronic type B dissection.胸主动脉腔内修复术后治疗急性和慢性 B 型夹层的二次主动脉干预的意义。
J Vasc Surg. 2019 May;69(5):1367-1378. doi: 10.1016/j.jvs.2018.07.080. Epub 2018 Dec 13.
8
Predictors of late aortic intervention in patients with medically treated type B aortic dissection.药物治疗的 B 型主动脉夹层患者晚期主动脉介入治疗的预测因素。
J Vasc Surg. 2018 Jan;67(1):78-84. doi: 10.1016/j.jvs.2017.05.128. Epub 2017 Sep 11.
9
Risk factors for stent graft-induced new entry after thoracic endovascular aortic repair for Stanford type B aortic dissection.Stanford B型主动脉夹层腔内修复术后支架移植物引起新破口的危险因素。
J Vasc Surg. 2017 Mar;65(3):676-685. doi: 10.1016/j.jvs.2016.09.022.
10
A geometric reappraisal of proximal landing zones for thoracic endovascular aortic repair according to aortic arch types.根据主动脉弓类型对胸主动脉腔内修复近端着陆区进行几何重新评估。
J Vasc Surg. 2017 Jun;65(6):1584-1590. doi: 10.1016/j.jvs.2016.10.113. Epub 2017 Feb 20.